🇬🇧#BATS #вакцина
BRITISH AMERICAN TOBACCO МОДИФИЦИРОВАЛИ СВОЮ АНТИКОВИДНУЮ ВАКЦИНУ, ЧТОБЫ БЫСТРЕЕ НАЧАТЬ ФАЗУ1 КЛИНИЧЕСКИХ ИСПЫТАНИЙ - СМИ

BRITISH AMERICAN TOBACCO HAS MODIFIED COVID-19 VACCINE TO ENTER PHASE 1 CLINICAL TESTING ASAP

🇬🇧#BATS #weed
British American Tobacco, владеющая брендами Kent и Lucky Strike, решила выйти на рынок марихуаны - Forbes
————————-
👉 Мексика легализовала марихуану

👉 Байден обещал декриминализацию марихуаны

🇬🇧#BATS #отчетность #прогноз
British American Tobacco - FY 2021 expectations:

o Upgraded constant currency revenue growth of above 5%, ahead of our 3-5% guidance

o Mid-single digit adjusted diluted constant currency EPS growth

o Strong operating cashflow conversion in excess of 90%

o Leverage reducing to around c.3x Adjusted Net debt4/ Adjusted EBITDA5 by year end

We continue to expect 2021 to be a pivotal year for the business, with accelerating New Category revenue growth, a clear pathway to New Category profitability by 2025, and leverage reducing to c.3x by year end

⚡️🇬🇧#BATS #отчетность
British American Tobacco H121 Earnings:
Revenue: GBP12.18B (est GBP12.14B)
Operating Profit: GBP4.91B
Adj EPS: GBP1.542

⚡️🇬🇧#BATS #отчетность
British American Tobacco FY Earnings:
- FY Adj. Oper Profit GBP11.15B, Est. GBP11.2B
- FY Rev. GBP25.68B, Est. GBP25.59B
- FY Div/Shr 217.8p
- Board Has Approved GBP2B Share Repurchase Program For 2022
- Sees 2022 Ex FX Reb Growth Of 3-5%

⚡️🇬🇧#BATS
British American Tobacco 1H 22 Earnings:
- Revenue: £12.87B (est £12.79B)
- Confident In Achieving FY Guidance
- Still See’s FY Revenue Ex-FX +2%-+4%

🇬🇧🇷🇺#BATS
British American Tobacco объявила о продаже бизнеса в России

🇬🇧🇷🇺#BATS
British American Tobacco закрыла сделку по продаже своего бизнеса в России и Беларуси — ТАСС